| Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend)  |
| GABRG3 |
gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
15q12 |
1(0/1/0)
|
| GRID1 |
glutamate receptor, ionotropic, delta 1 |
10q22 |
1(0/0/1)
|
| ADRA1B |
adrenoceptor alpha 1B |
5q33.3 |
1(1/0/0)
|
| CHRM4 |
cholinergic receptor, muscarinic 4 |
11p12-p11.2 |
1(0/1/0)
|
| P2RX4 |
purinergic receptor P2X, ligand gated ion channel, 4 |
12q24.32 |
1(0/1/0)
|
| CNR2 |
cannabinoid receptor 2 (macrophage) |
1p |
1(1/0/0)
|
| GRIA3 |
glutamate receptor, ionotropic, AMPA 3 |
Xq25 |
1(0/1/0)
|
| GRIK3 |
glutamate receptor, ionotropic, kainate 3 |
1p34.3 |
1(1/0/0)
|
| DRD2 |
dopamine receptor D2 |
11q22-q23 |
28(8/20/0)
|
| GABRA5 |
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
15q12 |
6(6/0/0)
|
| GABRB1 |
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
4p12 |
3(2/0/1)
|
| GRIN3A |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A |
9q31.1 |
1(0/1/0)
|
| TAAR6 |
trace amine associated receptor 6 |
6q23.1 |
5(4/1/0)
|
| ADRA1A |
adrenoceptor alpha 1A |
8p21.2 |
2(0/2/0)
|
| HCRTR2 |
hypocretin (orexin) receptor 2 |
6p12.1 |
1(1/0/0)
|
| DRD4 |
dopamine receptor D4 |
11p15.5 |
13(1/12/0)
|
| GABRA6 |
gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
5q34 |
1(0/1/0)
|
| GPR50 |
G protein-coupled receptor 50 |
Xq28 |
3(2/1/0)
|
| HTR1F |
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
3p12 |
1(1/0/0)
|
| NTSR2 |
neurotensin receptor 2 |
2p25.1 |
1(1/0/0)
|
| PTGFR |
prostaglandin F receptor (FP) |
1p31.1 |
1(1/0/0)
|
| SSTR5 |
somatostatin receptor 5 |
16p13.3 |
2(1/1/0)
|
| HTR5A |
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
7q36.1 |
2(1/1/0)
|
| GLRA1 |
glycine receptor, alpha 1 |
5q33.1 |
1(1/0/0)
|
| CCKBR |
cholecystokinin B receptor |
11p15.4 |
1(1/0/0)
|
| HTR2C |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
Xq23 |
7(4/3/0)
|
| ADRB2 |
adrenoceptor beta 2, surface |
5q31-q32 |
1(1/0/0)
|
| GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
12p13.1 |
8(4/4/0)
|
| DRD3 |
dopamine receptor D3 |
3q13.3 |
19(4/15/0)
|
| BDKRB1 |
bradykinin receptor B1 |
14q32.1-q32.2 |
1(1/0/0)
|
| CHRM5 |
cholinergic receptor, muscarinic 5 |
15q26 |
1(0/1/0)
|
| NMUR2 |
neuromedin U receptor 2 |
5q33.1 |
1(0/1/0)
|
| MCHR2 |
melanin-concentrating hormone receptor 2 |
6q16 |
1(1/0/0)
|
| HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
1p36-p35 |
3(1/2/0)
|
| ADRA2C |
adrenoceptor alpha 2C |
4p16.3 |
1(0/1/0)
|
| CRHR2 |
corticotropin releasing hormone receptor 2 |
7p14.3 |
3(2/1/0)
|
| GABRA3 |
gamma-aminobutyric acid (GABA) A receptor, alpha 3 |
Xq28 |
3(1/2/0)
|
| GRM2 |
glutamate receptor, metabotropic 2 |
3p21.2 |
1(0/1/0)
|
| DRD5 |
dopamine receptor D5 |
4p16.1 |
2(0/2/0)
|
| GABRB2 |
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
5q34 |
1(1/0/0)
|
| GRIK4 |
glutamate receptor, ionotropic, kainate 4 |
11q23.3 |
2(1/1/0)
|
| GABRA1 |
gamma-aminobutyric acid (GABA) A receptor, alpha 1 |
5q34 |
2(1/1/0)
|
| NPFFR2 |
neuropeptide FF receptor 2 |
4q21 |
1(0/1/0)
|
| DRD1 |
dopamine receptor D1 |
5q34-q35 |
11(6/5/0)
|
| ADRA2A |
adrenoceptor alpha 2A |
10q25.2 |
1(0/1/0)
|
| CHRM2 |
cholinergic receptor, muscarinic 2 |
7q35-q36 |
1(0/1/0)
|
| OXTR |
oxytocin receptor |
3p25 |
1(0/1/0)
|
| GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
1(1/0/0)
|
| HTR4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
5q31-q33 |
2(1/1/0)
|
| HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
22(7/15/0)
|
| TAAR8 |
trace amine associated receptor 8 |
6q23.2 |
1(0/1/0)
|
| GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
9q34.3 |
3(2/1/0)
|
| P2RX7 |
purinergic receptor P2X, ligand gated ion channel, 7 |
12q24 |
9(2/7/0)
|
| NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
5q31-q32 |
5(2/3/0)
|
| GRIK2 |
glutamate receptor, ionotropic, kainate 2 |
6q16.3 |
3(1/1/1)
|
| GRIN2D |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
19q13.33 |
1(1/0/0)
|
| CRHR1 |
corticotropin releasing hormone receptor 1 |
17q21.31 |
4(2/2/0)
|
| GABRA4 |
gamma-aminobutyric acid (GABA) A receptor, alpha 4 |
4p12 |
2(2/0/0)
|
| SSTR1 |
somatostatin receptor 1 |
14q13 |
1(1/0/0)
|
| TACR1 |
tachykinin receptor 1 |
2p13.1-p12 |
3(3/0/0)
|
| GRIK5 |
glutamate receptor, ionotropic, kainate 5 |
19q13.2 |
2(1/0/1)
|
| TSHR |
thyroid stimulating hormone receptor |
14q24-q31 |
1(1/0/0)
|
| GABRB3 |
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
15q12 |
3(1/2/0)
|
| GRM4 |
glutamate receptor, metabotropic 4 |
6p21.3 |
2(2/0/0)
|
| PRLR |
prolactin receptor |
5p14-p13 |
1(1/0/0)
|
| TSPO |
translocator protein (18kDa) |
22q13.3 |
3(1/2/0)
|
| CHRM1 |
cholinergic receptor, muscarinic 1 |
11q12-q13 |
1(0/1/0)
|
| GRM7 |
glutamate receptor, metabotropic 7 |
3p26-p25 |
3(2/1/0)
|
| AGTR1 |
angiotensin II receptor, type 1 |
3q24 |
1(1/0/0)
|
| CNR1 |
cannabinoid receptor 1 (brain) |
6q14-q15 |
5(0/5/0)
|
| HCRTR1 |
hypocretin (orexin) receptor 1 |
1p33 |
1(1/0/0)
|
| P2RY13 |
purinergic receptor P2Y, G-protein coupled, 13 |
3q24 |
1(1/0/0)
|
| GRIA1 |
glutamate receptor, ionotropic, AMPA 1 |
5q33 |
2(2/0/0)
|
| MTNR1A |
melatonin receptor 1A |
4q35 |
1(0/1/0)
|
| HTR1D |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
1p36.3-p34.3 |
1(0/1/0)
|
| GABBR2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
9q22.1-q22.3 |
2(0/2/0)
|
| CHRM3 |
cholinergic receptor, muscarinic 3 |
1q43 |
1(0/1/0)
|
| THRA |
thyroid hormone receptor, alpha |
17q21.1 |
1(1/0/0)
|
| MC5R |
melanocortin 5 receptor |
18p11.2 |
1(0/1/0)
|
| AVPR1B |
arginine vasopressin receptor 1B |
1q32 |
4(3/1/0)
|
| TRHR |
thyrotropin-releasing hormone receptor |
8q23.1 |
1(0/1/0)
|
| VIPR2 |
vasoactive intestinal peptide receptor 2 |
7q36.3 |
1(1/0/0)
|
| BDKRB2 |
bradykinin receptor B2 |
14q32.1-q32.2 |
1(1/0/0)
|
| TAAR1 |
trace amine associated receptor 1 |
6q23.1 |
1(0/1/0)
|
| MCHR1 |
melanin-concentrating hormone receptor 1 |
22q13.3 |
2(1/1/0)
|
| HTR1E |
5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled |
6q14-q15 |
1(0/1/0)
|
| HTR7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
10q21-q24 |
2(0/2/0)
|
| GRM3 |
glutamate receptor, metabotropic 3 |
7q21.1-q21.2 |
7(3/4/0)
|
| GABRR1 |
gamma-aminobutyric acid (GABA) A receptor, rho 1 |
6q15 |
1(1/0/0)
|
| LEPR |
leptin receptor |
1p31 |
1(1/0/0)
|
| ADORA2B |
adenosine A2b receptor |
17p12 |
1(1/0/0)
|
| HTR1A |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
5q11.2-q13 |
3(2/1/0)
|
Basic Info
